| P- Value | Odds Ratio (OR) 95% Confidence Interval | Group II (n = 20) Responders | Group I (n = 40) | Risk Factors | |||
| % | No | % | No | ||||
| 1.000 | R | 70 | 14 | 70 | 28 | Male | Gender |
| 1.0 (0.191 - 5.241) | 30 | 6 | 30 | 12 | Female | ||
| 0.026 | R | 50 | 10 | 10 | 4 | <40 | Age |
| 9.0 (1.325 - 61.138) | 50 | 10 | 90 | 36 | >40 | ||
| 0.000 | R | 100 | 20 | 15 | 6 | <600,000 | HCV-PCR |
| -- | 0 | 0 | 85 | 34 | >600,000 | ||
| 0.004 | R | 80 | 16 | 25 | 10 | 2(a&b) + 3(a&b) | HCV-Genotype |
| 12.0 (1.89 - 76.83) | 20 | 4 | 75 | 30 | 4 + 1(a&b) | ||
| 0.004 | R | 80 | 16 | 20 | 8 | <55 | ALT |
| 16.0 (2.39 - 106.73) | 20 | 4 | 80 | 32 | >55 | ||
| 0.000 | R | 70 | 14 | 5 | 2 | <55 | AST |
| 44.33 (3.92 - 500.26) | 30 | 6 | 95 | 38 | >55 | ||
| 0.001 | R | 100 | 20 | 35 | 14 | 1 + 2 | A |
| -- | 0 | 0 | 65 | 26 | 3 | ||
| 0.000 | R | 100 | 20 | 30 | 12 | 1 + 2 | F |
| -- | 0 | 0 | 70 | 28 | 3 | ||